-
Expert Spotlight: Exploring Peptide Therapy’s Potential in Women’s Reproductive Health
An OB/GYN specialist discusses how peptide therapy is being explored as a complementary approach for conditions like PCOS, endometriosis, and fertility support. The conversation highlights growing physician interest in peptides for women’s health.
-
FDA Approves MIMRYLO (Rusfertide), a Hepcidin Mimetic Peptide, for Polycythemia Vera
Protagonist Therapeutics has received U.S. FDA approval for MIMRYLO (rusfertide), a first-in-class hepcidin mimetic peptide designed to help manage polycythemia vera. The approval marks a significant milestone for peptide-based therapies in blood disorders.
-
New Trial Explores Gentler Chemo Combined With Antibody Therapy for Childhood Neuroblastoma
A newly launched clinical trial (N10) is investigating whether reducing chemotherapy intensity, combined with monoclonal antibody-based immunotherapy, can safely and effectively treat children with high-risk neuroblastoma.
-
New Phase 3 Trial Explores Adding Immunotherapy to Chemotherapy for Metastatic Anal Cancer
A national Phase 3 trial (EA2176) is testing whether adding the immunotherapy drug nivolumab to standard chemotherapy improves outcomes for patients with metastatic anal cancer.
-
New Clinical Trial Explores Combination Peptide-Based Strategy for HIV Remission
A new study is testing whether a combination therapy regimen, given alongside standard antiretroviral treatment, can help the immune system control HIV without continuous medication. Twenty participants will help researchers learn if durable remission is achievable.
-
New Clinical Trial to Explore How Exercise Can Protect Muscle and Bone During GLP-1 Weight Loss
A newly registered study, GRAMS, will examine how GLP-1 receptor-based weight loss therapies affect muscle and bone health, and whether structured exercise can help preserve musculoskeletal strength during treatment.
-
New Clinical Trial Explores Vorinostat for Difficult-to-Treat Crohn’s Disease
A new NIH-sponsored study is investigating whether the peptide-related compound vorinostat, followed by maintenance therapy with ustekinumab, could offer a fresh option for adults with moderate-to-severe Crohn’s disease that hasn’t responded to standard treatments.
-
New Clinical Trial Explores Expanding Bone Marrow Transplant Options for Chronic Granulomatous Disease Patients
A new trial is investigating whether partially-matched family donors can safely provide curative bone marrow transplants for people with Chronic Granulomatous Disease who lack a perfect match.
-
New Clinical Trial Compares Two Approaches to Spinal Fusion Bone Grafting
A newly registered clinical trial is examining how a bone graft substitute called ViviGen compares to recombinant human bone morphogenetic protein-2 (rhBMP-2) in helping patients achieve successful spinal fusion.
-
New Clinical Trial Explores NAC to Protect Lungs During Cancer Radiation Therapy
A phase II trial is investigating whether N-acetylcysteine, alone or with short-course corticosteroids, can help reduce respiratory symptoms in lung cancer patients with interstitial lung disease undergoing radiation therapy.